OptionsHouse

Options Trading News

July 16, 2013  Tue 3:16 AM CT

VRTX: SEE CHART GET CHAIN FIND STRATEGIES
A trader is looking for Vertex Pharmaceuticals to hold firm through the end of this week.

optionMONSTER's tracking systems detected the sale of 1,856 July 82.50 puts for an average price of $0.45 in less than 4 minutes yesterday. The volume was nearly 10 times higher than the strike's open interest of just 190 contracts before the trade appeared, indicating that this is a new position.

The put seller will keep the $0.45 credit as profit if VRTX stays above $82.50 through expiration at the end of Friday's session. If it falls below that strike price, the trader will be on the hook to buy shares at that level. (See our Education section)

VRTX was down 1.18 percent yesterday to $86.75. The drug developer gapped up from below $53 in April on positive data regarding its treatment of symptoms related to cystic fibrosis, but shares have been trading mostly sideways since then. The company is scheduled to report its next quarterly results on July 29 after the close.

Total volume in the name topped 5,300 contracts, triple its daily average for the last month.
Share this article with your friends


Related Stories

VRTX

Vertex draws upside bet before earnings

January 26, 2016

A February call spread is bullish on the drug developer, which announces quarterly results after the market closes tomorrow.

OptionsHouse

Premium Services

Upcoming Webinar:

Using Options For Income

http://bit.ly/1nY1OKA

Jon Najarian and Adam Mesh of Options Wealth Machine discuss a detailed strategy utilizing credit spreads to generate income, and how any level of trader can use this simple trading technique.

Education & Strategy

Sweet Spot Exceptions

As discussed last week, when using the Stock Replacement Strategy to replace a stock position to trade direction, we want to use an option that has very similar characteristics to the stock. We talked about using the deep in-the-money, 80 to 85 delta option that is similar in the Greeks and has relatively little extrinsic value which tends to work against us in stock directional trading.

View more education articles »